TCM
Tao Capital Management Portfolio holdings
AUM
$136M
This Quarter Return
+0.25%
1 Year Return
+59.51%
3 Year Return
+522.02%
5 Year Return
+487.63%
10 Year Return
–
AUM
$106M
AUM Growth
+$106M
(-3.4%)
Cap. Flow
-$120K
Cap. Flow
% of AUM
-0.11%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
12
New
–
Increased
–
Reduced
–
Closed
2
Top Buys
No buys this quarter
Top Sells
| 1 |
Denali Therapeutics
DNLI
|
$66K |
| 2 |
Scholar Rock
SRRK
|
$54K |
Sector Composition
| 1 | Healthcare | 66.02% |
| 2 | Consumer Discretionary | 25.18% |
| 3 | Technology | 8.47% |
| 4 | Consumer Staples | 0.34% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Madrigal Pharmaceuticals
MDGL
$9.76B
| $34.9M | 33.02% | 130,529 | – | – |
|
2
Twist Bioscience
TWST
$1.63B
| $28.4M | 26.94% | 828,815 | – | – |
|
3
Tesla
TSLA
$1.08T
| $15.2M | 14.37% | 86,250 | – | – |
|
4
Hyatt Hotels
H
$13.8B
| $11.2M | 10.59% | 70,000 | – | – |
|
5
Ouster
OUST
$1.65B
| $8.94M | 8.47% | 1,125,316 | – | – |
|
6
908 Devices
MASS
$226M
| $4.3M | 4.07% | 568,981 | – | – |
|
7
Warby Parker
WRBY
$3.2B
| $1.83M | 1.73% | 134,473 | – | – |
|
|
BHIL
8
DELISTED
Benson Hill, Inc.
BHIL
| $356K | 0.34% | 1,774,681 | – | – |
|
9
Ginkgo Bioworks
DNA
$750M
| $264K | 0.25% | 227,354 | – | – |
|
10
Sonder
SOND
$25.6M
| $237K | 0.22% | 80,188 | – | – |
|
|
11
Denali Therapeutics
DNLI
$2.23B
| – | – | -3,042 | Closed | -$66K |
|
|
12
Scholar Rock
SRRK
$3.14B
| – | – | -2,842 | Closed | -$54K |
|